203 related articles for article (PubMed ID: 9498771)
1. Induction of nuclear factor-kappa B during primary B cell differentiation.
Kistler B; Rolink A; Marienfeld R; Neumann M; Wirth T
J Immunol; 1998 Mar; 160(5):2308-17. PubMed ID: 9498771
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells.
Marienfeld R; Neumann M; Chuvpilo S; Escher C; Kneitz B; Avots A; Schimpl A; Serfling E
Eur J Immunol; 1997 Jul; 27(7):1601-9. PubMed ID: 9247567
[TBL] [Abstract][Full Text] [Related]
3. The subunit composition of NF-kappa B complexes changes during B-cell development.
Grumont RJ; Gerondakis S
Cell Growth Differ; 1994 Dec; 5(12):1321-31. PubMed ID: 7696180
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of the transcription factor NF-kappaB during human mononuclear phagocyte differentiation to macrophages and dendritic cells.
Ammon C; Mondal K; Andreesen R; Krause SW
Biochem Biophys Res Commun; 2000 Feb; 268(1):99-105. PubMed ID: 10652220
[TBL] [Abstract][Full Text] [Related]
5. CD40, but not lipopolysaccharide and anti-IgM stimulation of primary B lymphocytes, leads to a persistent nuclear accumulation of RelB.
Neumann M; Wohlleben G; Chuvpilo S; Kistler B; Wirth T; Serfling E; Schimpl A
J Immunol; 1996 Dec; 157(11):4862-9. PubMed ID: 8943389
[TBL] [Abstract][Full Text] [Related]
6. Differential nuclear localization of p50, p52, and RelB proteins in human accessory cells of the immune response in situ.
Feuillard J; Körner M; Israel A; Vassy J; Raphael M
Eur J Immunol; 1996 Nov; 26(11):2547-51. PubMed ID: 8921937
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation.
Rödel F; Hantschel M; Hildebrandt G; Schultze-Mosgau S; Rödel C; Herrmann M; Sauer R; Voll RE
Int J Radiat Biol; 2004 Feb; 80(2):115-23. PubMed ID: 15164793
[TBL] [Abstract][Full Text] [Related]
8. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
Sovak MA; Bellas RE; Kim DW; Zanieski GJ; Rogers AE; Traish AM; Sonenshein GE
J Clin Invest; 1997 Dec; 100(12):2952-60. PubMed ID: 9399940
[TBL] [Abstract][Full Text] [Related]
9. Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes.
Hsing Y; Hostager BS; Bishop GA
J Immunol; 1997 Nov; 159(10):4898-906. PubMed ID: 9366415
[TBL] [Abstract][Full Text] [Related]
10. Transcription of the RelB gene is regulated by NF-kappaB.
Bren GD; Solan NJ; Miyoshi H; Pennington KN; Pobst LJ; Paya CV
Oncogene; 2001 Nov; 20(53):7722-33. PubMed ID: 11753650
[TBL] [Abstract][Full Text] [Related]
11. I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity.
Whiteside ST; Epinat JC; Rice NR; Israël A
EMBO J; 1997 Mar; 16(6):1413-26. PubMed ID: 9135156
[TBL] [Abstract][Full Text] [Related]
12. Nuclear Rel-A and c-Rel protein complexes are differentially distributed within human thymocytes.
Feuillard J; Dargemont C; Ferreira V; Tarantino N; Debré P; Raphael M; Körner M
J Immunol; 1997 Mar; 158(6):2585-91. PubMed ID: 9058790
[TBL] [Abstract][Full Text] [Related]
13. I kappa B alpha can localize in the nucleus but shows no direct transactivation potential.
Cressman DE; Taub R
Oncogene; 1993 Sep; 8(9):2567-73. PubMed ID: 8361766
[TBL] [Abstract][Full Text] [Related]
14. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.
Cogswell PC; Guttridge DC; Funkhouser WK; Baldwin AS
Oncogene; 2000 Feb; 19(9):1123-31. PubMed ID: 10713699
[TBL] [Abstract][Full Text] [Related]
15. Deficient translocation of c-Rel is associated with impaired Th1 cytokine production in T cells from atopic dermatitis patients.
Dieckhoff K; Graf P; Beinhauer B; Schwaerzler C; Carballido JM; Neumann C; Zachmann K; Jung T
Exp Dermatol; 2005 Jan; 14(1):17-25. PubMed ID: 15660915
[TBL] [Abstract][Full Text] [Related]
16. Members of the NF-kappaB family expressed in zones of active neurogenesis in the postnatal and adult mouse brain.
Denis-Donini S; Caprini A; Frassoni C; Grilli M
Brain Res Dev Brain Res; 2005 Jan; 154(1):81-9. PubMed ID: 15617758
[TBL] [Abstract][Full Text] [Related]
17. Regulation of NFKB1 proteins by the candidate oncoprotein BCL-3: generation of NF-kappaB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation.
Watanabe N; Iwamura T; Shinoda T; Fujita T
EMBO J; 1997 Jun; 16(12):3609-20. PubMed ID: 9218802
[TBL] [Abstract][Full Text] [Related]
18. Distinct nuclear factor-kappaB/Rel proteins have opposing modulatory effects in glutamate-induced cell death in HT22 cells.
Ishige K; Tanaka M; Arakawa M; Saito H; Ito Y
Neurochem Int; 2005 Dec; 47(8):545-55. PubMed ID: 16183169
[TBL] [Abstract][Full Text] [Related]
19. RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF.
Yilmaz ZB; Weih DS; Sivakumar V; Weih F
EMBO J; 2003 Jan; 22(1):121-30. PubMed ID: 12505990
[TBL] [Abstract][Full Text] [Related]
20. RelA repression of RelB activity induces selective gene activation downstream of TNF receptors.
Jacque E; Tchenio T; Piton G; Romeo PH; Baud V
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14635-40. PubMed ID: 16192349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
